Remission of type 2 diabetes following a metabolic program including surgery: a comparative study of young-onset and older-onset type 2 diabetes
Authors' conclusion
In contrast to previous reports, our YT2DM cohort had a lower proportion of patients with complete diabetes remission at 12 months after MS. Variables such as baseline HbA1c and T2DM duration appeared as potentially important factors associated with remission.
Study context
- Population
- Adults with obesity and T2D who underwent metabolic surgery (MS) between 01/06/2018 and 31/05/2024 at an Australian tertiary hospital
- Exposure
- YT2DM vs OT2DM undergoing MS
- Outcome
- Complete diabetes remission: HbA1c < 6.0% (42 mmol/mol) and at least 3 months off glucose-lowering medications
- Follow-up
- 12 months following MS
Methodological detailssingle-centre (Australian tertiary hospital)
- Single-centre (Australian tertiary hospital)
Main finding
As reported in the abstract
Complete diabetes remission
P = 0.002
Observational data: associations, not effects.
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Remission of type 2 diabetes following a metabolic program including surgery: a comparative study of young-onset and older-onset type 2 diabetes. Diabetes Res Clin Pract. Published 26 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →